Commodore Capital

About Commodore Capital

Commodore Capital is an investment firm focused on biotech and biopharmaceutical companies, with a emphasis on innovative therapies that aim to improve patient lives. The firm believes that much of the next wave of medical breakthroughs will come from smaller biopharma companies, advancing novel modalities like genetic medicines and cellular therapies. Commodore positions itself as a partner to early-stage biotech companies as they translate scientific discoveries into safe and effective medicines for patients worldwide. Based in New York, the firm invests in opportunities that strive to accelerate clinical progress and meaningful patient outcomes.